登录新浪财经APP 搜索【信披】查看更多考评等级 根据万家国证港股通科技交易型开放式指数证券投资基金发起式联接基金（基金简称：万家国证港股通 科技ETF发起式联接；基金代码：A类：026107，C类：026108，以下简称"本基金"）招募说明书、基 金份额发售公告的规定，本基金自2025年11月19日至2025年11月26日通过万家基金管理有限公司（以下 简称"本公司"）指定的销售机构公开发售。 依照本公司与华宝证券股份有限公司（下文简称为"华宝证券"）签署的销售代理协议，自2025年11月19 日起，本公司将增加华宝证券代理本基金的基金发售业务，投资者可在华宝证券办理本基金的认购业 务。待基金成立后，投资者也可在华宝证券办理申购、赎回、转换、定投等其他业务。华宝证券可支持 办理认购的份额类别以及具体业务办理流程、规则等以各机构的规定为准，相关业务办理状况亦请遵循 其各自规定执行。 投资者可通过以下途径咨询详情： 1、华宝证券股份有限公司 客服电话：400-820-9898 网址：www.cnhbstock.com 万家基金管理有限公司 2025年11月19日 万家基金管理有限公司关于旗下部分基金新增国信证券 ...

Group 1 - Semiconductor equipment concept stocks declined, with Tuojing Technology falling over 6%, Changchuan Technology down over 5%, and Huahai Qingke and Xinyuan Micro both dropping over 4% [1] - Related semiconductor equipment ETFs also experienced a decline, with an overall drop of over 4% [1] Group 2 - Specific ETF performance included: - Semiconductor Materials ETF at 1.459, down 0.069 or 4.52% - Chip Equipment ETF at 1.530, down 0.071 or 4.43% - Semiconductor Equipment ETF Fund at 1.643, down 0.075 or 4.37% - Semiconductor Equipment ETF at 1.390, down 0.063 or 4.34% - E Fund Semiconductor Equipment ETF at 1.624, down 0.072 or 4.25% [2] Group 3 - Analysts indicate that under the backdrop of the AI wave and domestic substitution, there is a continuous demand for expansion in advanced production lines in China, positioning semiconductor equipment as a cornerstone for wafer foundry expansion and an important link for achieving self-sufficiency in the industry chain, presenting development opportunities for domestic semiconductor equipment manufacturers [2]

Group 1: Market Overview - The three major indices in the market rose collectively, with the Shanghai Composite Index increasing by 1.22%, the Shenzhen Component Index by 1.73%, and the ChiNext Index by 2.36% [1][4] - The electric equipment sector saw multiple ETFs rise, including the Battery 50 ETF (159796.SZ) up by 3.65%, Lithium Battery ETF (561160.SH) up by 3.64%, and Battery ETF by Harvest (562880.SH) up by 3.57% [1] Group 2: ETF Performance - Despite recent adjustments in growth stocks, funds continue to favor indices like the Sci-Tech 50 and ChiNext, with a "buy the dip" strategy observed in sectors like chips and large-cap stocks [2] - A total of 14 stock ETFs have seen net inflows exceeding 1 billion yuan this month, with industry-themed ETFs being particularly popular, including those focused on chips, non-ferrous metals, securities, batteries, and banks [2] Group 3: ETF Listings and Positions - In the past month, 24 stock ETFs were announced for listing, with an average position of only 22.66%. The highest position was 98.80% for the Chuangjin Hexin CSI State-Owned Enterprises Dividend ETF [3] - The average fundraising for the newly listed ETFs was 552 million units, with the top three being the Fortune National Robot Industry ETF, Guolian An CSI A500 Dividend Low Volatility ETF, and Fortune CSI Financial Technology Theme ETF [3] Group 4: Sector Performance - The electric equipment, automotive, and electronics sectors ranked high in daily performance, with daily increases of 2.72%, 2.37%, and 2.29% respectively [8] - Over the past five trading days, coal, non-ferrous metals, and steel sectors performed well, with increases of 7.02%, 5.53%, and 5.17% respectively [8] Group 5: ETF Categories and Transactions - Among different ETF categories, commodity ETFs performed the best with an average increase of 2.08%, while bond ETFs had the worst performance with an average decrease of 0.02% [9] - The top three stock ETFs by transaction volume today were the ChiNext ETF (159915.SZ) with 5.552 billion yuan, Sci-Tech 50 ETF (588000.SH) with 5.479 billion yuan, and A500 ETF (512050.SH) with 5.027 billion yuan [14]

Group 1 - Semiconductor equipment stocks experienced a decline in early trading, with Zhongke Feimeasure down over 6%, Fuchuang Precision down over 5%, Hu Silicon Industry down over 3%, and Nanda Optoelectronics down over 2% [1] - Several semiconductor-related ETFs also fell by more than 2% due to market conditions [1] Group 2 - The current demand in the semiconductor industry remains strong, and the domestic substitution is continuously advancing, indicating a good demand for domestic semiconductor equipment [2] - It is recommended to focus on the "domestic substitution" theme, particularly on companies that have achieved technological breakthroughs in key areas and have entered the mainstream chip manufacturing supply chain [2]

Core Insights - The ETF market showed mixed performance on the 18th, with the semiconductor sector leading gains [2] - The total trading volume for ETFs reached 297.14 billion yuan, with stock ETFs accounting for the largest share [2] Group 1: ETF Performance - The leading performer was the Penghua Sci-Tech Semiconductor ETF (589020), which rose by 6.90% [2] - Other notable gainers included the Semiconductor Materials ETF (562590) with a 6.65% increase and the Semiconductor Equipment ETF (159327) up by 6.53% [2] - The Rare Metals ETF (561800) was the biggest loser, declining by 1.96% [2] Group 2: Trading Volume Breakdown - The trading volume for stock ETFs was 126.15 billion yuan, while bond ETFs had a volume of 88.02 billion yuan [2] - Money market ETFs recorded a trading volume of 22.46 billion yuan, and commodity ETFs had 3.72 billion yuan [2] - The highest trading volumes among non-money market ETFs were for the Hang Seng Technology ETF (513130) at 7.13 billion yuan, followed closely by the Huaxia Hang Seng Technology ETF (513180) at 7.13 billion yuan and the Huaxia Hang Seng Internet Technology ETF (513330) at 7.00 billion yuan [2]

Group 1 - The semiconductor equipment ETF (159327) led the gains with an increase of 2.87% [1] - The E Fund semiconductor equipment ETF (159558) rose by 2.65% [1] - The chip equipment ETF (560780) saw an increase of 2.54% [1] Group 2 - The Southeast Asia technology ETF (513730) was the biggest loser, declining by 1.56% [1] - The consumption 30 ETF (510630) fell by 1.3% [1] - The communication ETF (515880) decreased by 1.27% [1]

Group 1 - The article highlights the significant interest from public funds in the semiconductor and general equipment sectors, with 125 public funds conducting intensive research on 210 A-shares from May 12 to May 18, 2025 [2][3] - The semiconductor industry led the research frequency with 76 instances, indicating strong expectations for domestic semiconductor replacement processes [4][5] - The general equipment sector followed with 60 research instances, reflecting institutional intentions for comprehensive layout in high-end equipment manufacturing [4][5] Group 2 - The semiconductor industry is expected to break through cycles, with historical experiences suggesting that tariff impacts are temporary and do not hinder overall economic development [6][7] - The domestic semiconductor market has seen substantial growth, with sales of semiconductor equipment projected to rise from under $20 billion in 2010 to nearly $50 billion by 2024 [7][8] - The article notes that more domestic manufacturers are entering the high-end chip industry, marking a significant rise in China's technological capabilities [11] Group 3 - The article discusses the contrasting performance of Chinese and American tech stocks in 2025, with Chinese tech stocks showing gains of over 20% to 30% while American tech stocks averaged a decline of 5.9% [12][13] - The rise of Chinese tech stocks is attributed to technological leaps, domestic replacement, and valuation recovery, with companies like Chip Origin seeing significant stock price increases despite previous losses [15][16] Group 4 - The innovative drug sector is experiencing a revolutionary moment, with a growing market space driven by an aging population and increased health investments [33][34] - The Hang Seng Healthcare Index has risen by 31.89% since the beginning of the year, outperforming other indices [36] - The article highlights a record-breaking agreement between a domestic pharmaceutical company and Pfizer, marking a significant milestone for domestic innovative drugs [38][39] Group 5 - The innovative drug industry is transitioning from a "follower" to a "leader" position, with a notable increase in the number of innovative drug pipelines and global first-in-class drugs [46][49] - The article mentions that the innovative drug sector has received substantial policy support across various stages, contributing to its growth [50] - The performance of innovative drug-related ETFs has been strong, with many achieving returns above 30% this year [47][49]